News square red

Network recruits over 40,000 patients into cancer trials in the West Midlands

Date: 06 February 2018

Over 40,000 people took part in cancer-related clinical trials throughout the region in the five years to the end of 2017, thanks to opportunities offered by the Clinical Research Network West Midlands.

 

The figures, released by the Network  to mark World Cancer Day this week, show that 41,277 participants were recruited into 610 high quality cancer-related studies across the region in the last five years.

 

Professor Jeremy Kirk, Clinical Director of the Network, commented: ‘It is a fantastic reflection of the hard work and enthusiasm of our dedicated staff and researchers within the Network that so many patients have had the opportunity to take part in vital clinical research. 

 

‘It is predicted that up to one in two people will develop cancer in their lifetime, and those taking part in research are helping to advance our medical knowledge all the time, so we are very grateful to them. Ultimately, clinical research means patients get access to new treatments, interventions and medicines, and investment in research means better, more cost-effective patient care.’

 

The Network’s Patient Research Ambassador for Cancer, Clare Wheatley says: ‘These are very exciting times right now. All the cancer research projects going on in the West Midlands, and around the country, are making huge strides in our battle with cancer. As a cancer survivor, I for one am extremely grateful. Plenty more to do, but thank you to those who work hard on our behalf.’

 

STAMPEDE is an example of a national study which includes sites* across the West Midlands. It has already delivered results which are benefitting patients with prostate cancer.  One part of the trial concluded that giving them chemotherapy early on, rather than waiting for the disease to progress, was beneficial and this is now standard practice. The trial continues to recruit patients with prostate cancer to address other research questions.

 

For more information about World Cancer Day 2018 visit:  www.worldcancerday.org 

 *Queen Elizabeth Hospital, Birmingham                   

Royal Shrewsbury Hospital

Queens Hospital, Burton on Trent                             

Hereford County Hospital

Worcestershire Royal Infirmary                                

Russells Hall Hospital, Dudley

New Cross Hospital, Wolverhampton                       

Kidderminster Hospital Birmingham City Hospital                                        

George Eliot Hospital, Nuneaton Good Hope Hospital, Sutton Coldfield                       

University Hospital Coventry

South Warwickshire NHS Foundation Trust     

Wye Valley NHS Trust

University Hospitals of North Midlands NHS Trust

 

For further information contact:

Claire Hall

Communications Lead

 01902 447207      claireanne.hall@nihr.ac.uk

 

NOTES TO EDITORS

The trial’s Chief Investigator is Professor Nick James at the Queen Elizabeth Hospital, Birmingham and it runs altogether in more than 100 sites nationally, coordinated by the Medical Research Council’s Clinical Trials Unit  at University College London.

For more information on STAMPEDE visit: http://www.stampedetrial.org/participants/about-stampede/

  • Summary:
    Over 40,000 people took part in cancer-related clinical trials throughout the region in the five years to the end of 2017, thanks to opportunities offered by the Clinical Research Network West Midlands.
  • Include on homepage (one at a time):
  • Areas of the site this news is applicable to:
  • LCRN:
    West Midlands
  • Year of publication:
    2018
  • Specialty:
    Cancer
  • News filter:
    NIHR in your area


You may also be interested in